Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	15.51B +102.3%
Revenue (ttm)	9.44B +24.4%
Net Income	1.44B +31.6%
EPS	8.90 +20.8%
Shares Out	168.76M
PE Ratio	10.33
Forward PE	10.62
Dividend	1.50 (1.63%)
Ex-Dividend Date	Apr 28, 2026

Volume	137,395
Average Volume	367,370
Open	91.89
Previous Close	91.89
Day's Range	91.10 - 92.10
52-Week Range	43.60 - 92.40
Beta	0.57
RSI	75.37
Earnings Date	May 21, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company provides analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolics; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It exports its products. The company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2025, EGX:PHAR's revenue was 9.44 billion, an increase of 24.38% compared to the previous year's 7.59 billion. Earnings were 1.44 billion, an increase of 31.57%.